US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

156.89

-2.4900-1.56%

Volume:7.18M

Turnover:1.13B

Market Cap:10.91B

PE:8.61

High:158.70

Open:157.40

Low:155.82

Close:159.38

52wk High:169.89

52wk Low:92.64

Shares:69.55M

Float Shares:69.55M

Volume Ratio:1.36

T/O Rate:10.32%

Dividend:0.57

Dividend Rate:0.37%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Table: Panion & BF Biotech Aug Rev Nt$181.2m vs Nt$251.3m

Fisher & Paykel Healthcare Issues New Unquoted Employee Options

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

Insider Move at Biotech Firm Sparks Fresh Investor Interest

Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett

Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup

Tenet Healthcare Prices Upsized $2 Billion Notes Offering

MT Newswires Live

Trinity Biotech Files 2025 Annual Report and AGM Materials with SEC

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference

Health Care Roundup: Market Talk

Cycurion Secures New Healthcare and Public Health Contracts

Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform

ICU Girişim Sermayesi Details Diversified Venture Portfolio in Healthcare and Technology

Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline

Sinovac Biotech Price Target Cut to $1.00/Share from $6.00 by HC Wainwright & Co.

Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), BioCryst (BCRX)

Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)

Sell Rating Reaffirmed on Weakening Core Franchise and Elevated Clinical Risk; $5 Price Target Unchanged

Greenland Mines (NASDAQ: GRML) Sets Q4 Biotech Spin-Off as Company Sharpens Critical Minerals Focus

Health Care Roundup: Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/XBI/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":156.89,"timestamp":1789066391575,"preClose":159.38,"halted":0,"volume":7176896,"delay":0,"changeRate":-0.015623039277199205,"floatShares":69550000,"shares":69550000,"eps":18.23,"marketStatus":"Trading","change":-2.49,"latestTime":"09-10 14:53:12 EDT","open":157.4,"high":158.7,"low":155.82,"amount":1127722031.80288,"amplitude":0.01807,"askPrice":156.9,"askSize":608,"bidPrice":156.84,"bidSize":25,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":159.38,"sharesOutstanding":63325000,"nav":161.918202,"aum":11172355927.14,"dividendRate":0.003657,"bidAskSpread":0.0003,"preHourTrading":{"tag":"盘前","latestPrice":157.6,"preClose":159.38,"latestTime":"09:29 EDT","volume":23758,"amount":3759554.06218,"timestamp":1789046999999,"change":-1.78,"changeRate":-0.011168,"amplitude":0.020646},"postHourTrading":{"tag":"盘后","latestPrice":159.35,"preClose":159.38,"latestTime":"19:55 EDT","volume":59882,"amount":9543147.209,"timestamp":1788998149275,"change":-0.03,"changeRate":-0.000188,"amplitude":0.002949},"volumeRatio":1.355336,"impliedVol":0.3143,"impliedVolPercentile":0.5657},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":69550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.355336,"shares":69550000,"dividePrice":0.5738,"high":158.7,"amplitude":0.01807,"preClose":159.38,"low":155.82,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.89,"committee":-0.921011,"eps":18.23,"divideRate":0.003657,"volume":7176896,"delay":0,"ttmEps":18.23,"open":157.4,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":165.37,"twentyDayClose":159.39,"sixtyDayClose":136.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666830723","title":"Table: Panion & BF Biotech Aug Rev Nt$181.2m vs Nt$251.3m","url":"https://stock-news.laohu8.com/highlight/detail?id=2666830723","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666830723?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:17","pubTimestamp":1788934620,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530127","title":"Fisher & Paykel Healthcare Issues New Unquoted Employee Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530127?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:17","pubTimestamp":1788923854,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an update. Fisher & Paykel Healthcare Corporation Limited has notified t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-issues-new-unquoted-employee-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FPH.NZ","BK4588","BK8004","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630973","title":"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630973?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:30","pubTimestamp":1788921013,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE0009355771.USD","LU0868494617.USD","XLV","BEAM","LU1983299246.USD","LU0889565916.HKD","LU2112291526.USD","BK4611","PBE","SG9999001440.SGD","BBH","BIB","IE00B4R5TH58.HKD","LU1861558580.USD","LU2242652126.USD","TBXU","BK4588","XBI","IE00B2B36J28.USD","LABU","RPRX","IE0002141913.USD","LU1061106388.HKD","BK4599","BK4137","AMGN","IE00BFTCPJ56.SGD","IBBQ","BK4505","LU1023059063.AUD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","IHE","LU0109394709.USD","BK4535","LU0029874061.USD","BK4533","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0320765992.SGD","IBB","BK4566","LU1861559042.SGD","LU2468319806.SGD","BK4534","HCSG","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309963","title":"Insider Move at Biotech Firm Sparks Fresh Investor Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309963","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309963?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:08","pubTimestamp":1788919689,"startTime":"0","endTime":"0","summary":"New insider activity at Alterity Therapeutics ( ($ATHE) ) has taken place on September 8, 2026. Director Peter Ashley Marks has strengthened his st...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-at-biotech-firm-sparks-fresh-investor-interest-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-at-biotech-firm-sparks-fresh-investor-interest-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309940","title":"Ramsay Health Care (RMSYF) Receives a Sell from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309940?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:06","pubTimestamp":1788919570,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst maintained a Sell rating on Ramsay Health Care today and set a price target of A$48.00. In addition to Ord Minnett, Ramsay Heal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-sell-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","BK4585","BK4581","BK4588","XBI","RMSYF","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666704053","title":"Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666704053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666704053?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:31","pubTimestamp":1788903060,"startTime":"0","endTime":"0","summary":"Health-care companies fell after growth warnings from two major medical-device makers and a disappointing clinical trial.Shares of Novartis plunged after one of the company's leading drug candidates failed to show significant progress on a late-stage trial on sufferers of a neuromuscular condition.Medical-device maker Boston Scientific said it likely would not meet its financial guidance due to the cyberattack that has disrupted its operations.Shares of Stryker declined after the maker of orthopedic implants and other medical technology said a lack of supply continues to hamper its peripheral vascular business.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU2362541513.USD","IE00B2B36J28.USD","LU0225283273.USD","LU1291159041.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","LU0267386448.USD","BK4504","XBI","SG9999001176.SGD","LU2324357040.USD","LU1023059063.AUD","LU2506951958.HKD","LU2362540622.SGD","BK4581","IE00B4R5TH58.HKD","LU1989764664.SGD","LU2357305700.SGD","BSX","LU0122379950.USD","LU0251132253.USD","LU0353189680.USD","LU1720051108.HKD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU0048584097.USD","LU1791710400.SGD","IE00BJT1NW94.SGD","LU1153585028.USD","LU2491050071.SGD","LABU","LU1791710582.SGD","SGXZ57979304.SGD","LU0138981039.USD","LU0823417737.USD","LU2242649171.HKD","LU1548497426.USD","LU0345769631.USD","LU1989771016.USD","LU0238689110.USD","LU0882574055.USD","LU2491049909.HKD","LU0266013472.USD","LU0823417653.USD","LU0187121727.USD","BK4082","LU1989764748.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370464","title":"Tenet Healthcare Prices Upsized $2 Billion Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370464","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370464?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:28","pubTimestamp":1788902911,"startTime":"0","endTime":"0","summary":"Tenet Healthcare  priced a private offering of $2 billion in senior notes due Sept. 15, 2034, bearing interest at 6.250% per annum, the company said late Tuesday.The offering was upsized from a previously announced $1.5 billion, with completion expected Sept. 22, the company said.Tenet said proceeds, along with cash on hand, will fund redemption of $1.5 billion of its 5.125% notes due 2027 and partial redemption of $500 million of its 6.125% notes due 2028.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","LABU","XLV","BK4588","LU0130103400.USD","BK4585","LU0648000940.SGD","HCSG","BK4185","BK4137","THC.AU","XBI","LU1201861165.SGD","LU0029874061.USD","THC","LU0128526141.USD","LU0963586101.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370031","title":"Trinity Biotech Files 2025 Annual Report and AGM Materials with SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370031?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:27","pubTimestamp":1788902859,"startTime":"0","endTime":"0","summary":"Trinity Biotech ( ($TRIB) ) has shared an announcement. On September 8, 2026, Trinity Biotech filed a Form 6-K with the U.S. Securities and Exchang...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trinity-biotech-files-2025-annual-report-and-agm-materials-with-sec?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trinity-biotech-files-2025-annual-report-and-agm-materials-with-sec?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","UYM","BK4588","TRN","BK4149","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666689370","title":"Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666689370","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666689370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:05","pubTimestamp":1788901500,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Ser","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358168/0/en/strata-critical-to-present-at-the-2026-jefferies-healthcare-services-and-technology-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LABU","BK4585","HCSG","BK4581","XLV","BK4588","LU0029874061.USD","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370898","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370898?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:50","pubTimestamp":1788900600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0417 ET - Novartis's latest clinical-trial failure suggests the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","XLV","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372275","title":"Cycurion Secures New Healthcare and Public Health Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372275","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372275?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:47","pubTimestamp":1788896876,"startTime":"0","endTime":"0","summary":"Cycurion ( ($CYCU) ) has shared an update. On September 3, 2026, Cycurion announced new engagements totaling about $800,000 in annual contract spen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cycurion-secures-new-healthcare-and-public-health-contracts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cycurion-secures-new-healthcare-and-public-health-contracts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LABU","BK4137","BK4585","CYCU","HCSG","XBI","LU0029874061.USD","XLV","BK4581","BK4123","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372293","title":"Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372293","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372293?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:45","pubTimestamp":1788896725,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from Wedbush maintained a Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sarepta-keeping-35-price-target-amid-confidence-in-dm1-franchise-and-integrin-delivery-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sarepta-keeping-35-price-target-amid-confidence-in-dm1-franchise-and-integrin-delivery-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666273374","title":"ICU Girişim Sermayesi Details Diversified Venture Portfolio in Healthcare and Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666273374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666273374?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:12","pubTimestamp":1788891143,"startTime":"0","endTime":"0","summary":"ICU Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:ICUGS) ) has provided an announcement. ICU Girişim Sermayesi Yatırım Ortaklığı A.Ş. has detaile...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icu-girisim-sermayesi-details-diversified-venture-portfolio-in-healthcare-and-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icu-girisim-sermayesi-details-diversified-venture-portfolio-in-healthcare-and-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","XLV","LABU","HCSG","BK4585","BK4588","LU0128526141.USD","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374136","title":"Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374136?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:55","pubTimestamp":1788890117,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Dennis Ding from Jefferies reiterated ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/dennis-ding-reiterates-buy-on-tarsus-highlighting-robust-xdemvy-trends-conservative-2026-guidance-and-attractive-valuation-backed-by-late-stage-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/dennis-ding-reiterates-buy-on-tarsus-highlighting-robust-xdemvy-trends-conservative-2026-guidance-and-attractive-valuation-backed-by-late-stage-pipeline-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","LABU","TARS","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374626","title":"Sinovac Biotech Price Target Cut to $1.00/Share from $6.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374626","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374626?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:47","pubTimestamp":1788889620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SVA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVA","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374637","title":"Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), BioCryst (BCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374637?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:20","pubTimestamp":1788888012,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and BioCryst (BCRX) with b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spyre-therapeutics-syre-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-spyre-therapeutics-syre-biocryst-bcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLV","LU0128526141.USD","HCSG","BK4547","BK4588","LU0029874061.USD","SYRE","BK4585","LABU","XBI","LFSC","BCRX","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666275371","title":"Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666275371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666275371?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:40","pubTimestamp":1788885608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on enGene Holdings (ENGN) and Structure Therapeutics, I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-engene-holdings-engn-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-engene-holdings-engn-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HCSG","BK4599","SAPH","XLV","DIVL","LU0128526141.USD","AADR","XBI","ENGN","CVY","LU0029874061.USD","BK4588","BK4137","ARMH","BK4581","BK4585","LABU","DINT","GPCR","BK4139","APIE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371411","title":"Sell Rating Reaffirmed on Weakening Core Franchise and Elevated Clinical Risk; $5 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371411?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:35","pubTimestamp":1788885338,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mitchell Kapoor from H.C. Wainwright rei...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sell-rating-reaffirmed-on-weakening-core-franchise-and-elevated-clinical-risk-5-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sell-rating-reaffirmed-on-weakening-core-franchise-and-elevated-clinical-risk-5-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371415","title":"Greenland Mines (NASDAQ: GRML) Sets Q4 Biotech Spin-Off as Company Sharpens Critical Minerals Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371415","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371415?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:30","pubTimestamp":1788885036,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 8th, 2026, FinanceWire Greenland Mines (NASDAQ:GRML) announced a series of corporate milestones as it trans...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/greenland-mines-nasdaq-grml-sets-q4-biotech-spin-off-as-company-sharpens-critical-minerals-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/greenland-mines-nasdaq-grml-sets-q4-biotech-spin-off-as-company-sharpens-critical-minerals-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","TECS","QLD","QQQM","BK4139","FTEC","QQQ","BK4109","QQQA","QQQY","SQQQ","QDTE","GRML",".IXIC","MNQmain","BK4581","QQQE","BK4585","JEPQ","NQmain","NVIW.SI","BK4588","03086","XBI","ONEQ","TQQQ","GPIQ","PSQ","QYLG","MTX","NDX","TQQY","QID","IYW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371944","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371944?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:20","pubTimestamp":1788884400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0417 ET - Novartis's latest clinical-trial failure suggests the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","XLV","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":4,"totalSize":364,"code":"91000000","status":"200"}]}}